CARBAMAZEPINE Safety Questions, CARBAMAZEPINE Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about CARBAMAZEPINE. Our extensive database of CARBAMAZEPINE adverse events and CARBAMAZEPINE warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about CARBAMAZEPINE
CARBAMAZEPINE Safety Reports
Total CARBAMAZEPINE reports: 354.CARBAMAZEPINE FDA safety alerts: 2004 2005 2007 .
Reported deaths: 54 Reported hospitalizations: 189.
Take CARBAMAZEPINE Side Effects Survey or Share Your CARBAMAZEPINE Story. CARBAMAZEPINE Usage.
Showing 1-50 of 354 Next >
Physician from TURKEY reported CARBAMAZEPINE problem on Mar 20, 2007. Female patient, child 12 years of age, was diagnosed with epilepsy and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: grand mal convulsion, haemodialysis, loss of consciousness, miosis, overdose, pupillary reflex impaired, somnolence, treatment noncompliance. CARBAMAZEPINE dosage: unknown. During the same period patient was treated with PHENYTOIN. Patient was hospitalized. Patient recovered.CARBAMAZEPINE problem was reported by a Physician from TURKEY on Mar 20, 2007. Male patient, 14 years of age, was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: body temperature decreased, haemodialysis, loss of consciousness, overdose, pupillary reflex impaired, respiratory rate increased, unresponsive to stimuli. CARBAMAZEPINE dosage: 300 MG X 20 TABLETS, ORAL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED KINGDOM reported CARBAMAZEPINE problem on Mar 26, 2007. Female patient was diagnosed with convulsion and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: hypogammaglobulinaemia. CARBAMAZEPINE dosage: unknown. Patient recovered.
CARBAMAZEPINE problem was reported by a Health Professional from UNITED STATES on Mar 23, 2007. Male patient, 26 years of age, was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: blood potassium decreased, brugada syndrome, cardiac failure, cardiogenic shock, coma, electroencephalogram abnormal, electromechanical dissociation, hyporeflexia, hypothermia. CARBAMAZEPINE dosage: 3200 MG; X1; PO. During the same period patient was treated with INSULIN. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported CARBAMAZEPINE problem on Mar 28, 2007. Male patient, 46 years of age, was diagnosed with schizophrenia and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: blood sodium increased, central nervous system lesion, csf test abnormal, diabetes insipidus. CARBAMAZEPINE dosage: 600 MG DAILY. During the same period patient was treated with PROMETHAZINE, LITHIUM CARBONATE, NIMETAZEPAM, OXATOMIDE, LISPERIDONE, BULOTIZOLAM. Patient was hospitalized. Patient recovered.
CARBAMAZEPINE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 22, 2007. Male patient, 82 years of age, was diagnosed with epilepsy and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: convulsion, grand mal convulsion. CARBAMAZEPINE dosage: 400MG, BID, ORAL. During the same period patient was treated with BENICAR. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED KINGDOM reported CARBAMAZEPINE problem on Apr 04, 2007. Female patient, 68 years of age, was diagnosed with trigeminal neuralgia, hypertension, hypothyroidism, transient ischaemic attack and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: dyskinesia, gait disturbance. CARBAMAZEPINE dosage: 100 MG, BID. During the same period patient was treated with DOXAZOSIN MESYLATE, ENALAPRIL MALEATE, LEVOTHYROXINE, SIMVASTATIN. Patient recovered.
CARBAMAZEPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 04, 2007. Male patient, 71 years of age, weighting 269.0 lb, was diagnosed with epilepsy, obesity and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: epilepsy. CARBAMAZEPINE dosage: 200 MG, TID. During the same period patient was treated with PHENYTOIN, XENICAL. Patient recovered.
Physician from INDIA reported CARBAMAZEPINE problem on Mar 26, 2007. Male patient was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: arteriovenous malformation, brain compression, cerebral haematoma, clonus, convulsion neonatal, csf protein increased, csf test abnormal. CARBAMAZEPINE dosage: 900 MG QD TRANSPLACENTAL. Patient was hospitalized. Patient died.
CARBAMAZEPINE problem was reported by a Health Professional from UNITED STATES on Apr 06, 2007. Male patient, 26 years of age, was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: cardiogenic shock, coma, electromechanical dissociation, hyporeflexia, hypothermia, hypotonia, myocardial infarction, overdose, renal failure acute. CARBAMAZEPINE dosage: 3200 MG;X1;PO. During the same period patient was treated with INSULIN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported CARBAMAZEPINE problem on Apr 02, 2007. Male patient, 46 years of age, was diagnosed with agitation and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: catatonia, central nervous system lesion, diabetes insipidus, nuclear magnetic resonance imaging brain abnormal, schizophrenia, stupor. CARBAMAZEPINE dosage: 600 MG QD. During the same period patient was treated with LITHIUM CARBONATE, PROMETHAZINE, FLUNITRAZEPAM, BULOTIZOLAM, NIMETAZEPAM, OXATOMIDE. Patient was hospitalized. Patient recovered.
CARBAMAZEPINE problem was reported by a Consumer or non-health professional from BRAZIL on Apr 02, 2007. Male patient, 35 years of age, was diagnosed with epilepsy and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: blood cholesterol increased, high density lipoprotein decreased, hypertriglyceridaemia. CARBAMAZEPINE dosage: unknown. Patient recovered.
Health Professional from INDIA reported CARBAMAZEPINE problem on Mar 28, 2007. Female patient, weighting 8.38 lb, was diagnosed with epilepsy and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: arteriovenous malformation, csf protein increased, dysmorphism, foetal anticonvulsant syndrome, haematoma, haemorrhage intracranial, hydrocephalus, hypertelorism of orbit. CARBAMAZEPINE dosage: 900 MG DAILY, TRANSPLACENTAL. Patient died.
CARBAMAZEPINE problem was reported by a Physician from GERMANY on Apr 03, 2007. Female patient, 54 years of age, was diagnosed with convulsion prophylaxis and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: blood potassium decreased, disorientation, grand mal convulsion, hyponatraemia, suicidal ideation. CARBAMAZEPINE dosage: 600MG DAILY, 200 MG, DAILY. During the same period patient was treated with DIAZEPAM, BROMAZEPAM. Patient recovered.
Physician from INDIA reported CARBAMAZEPINE problem on Apr 16, 2007. Male patient was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: arteriovenous malformation, clonus, crying, csf protein increased, dysmorphism, foetal anticonvulsant syndrome, haematoma, haemorrhage intracranial. CARBAMAZEPINE dosage: 900 MG QD TRANSPLACENTAL. Patient was hospitalized. Patient died.
CARBAMAZEPINE problem was reported by a Physician from GERMANY on Apr 09, 2007. Female patient, 54 years of age, was diagnosed with convulsion prophylaxis and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: disorientation, grand mal convulsion, hepatic steatosis, hyponatraemia, renal cyst, renal impairment, suicidal ideation. CARBAMAZEPINE dosage: 200 MG. During the same period patient was treated with DIAZEPAM. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from GERMANY reported CARBAMAZEPINE problem on Apr 12, 2007. Male patient, 46 years of age, was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: hallucination, auditory, hepatotoxicity, pneumonia, pyrexia. CARBAMAZEPINE dosage: 1000 MG. During the same period patient was treated with VENLAFAXINE, LORAZEPAM. Patient was hospitalized. Patient recovered.
CARBAMAZEPINE problem was reported by a Health Professional from SPAIN on Apr 16, 2007. Male patient, 74 years of age, was diagnosed with neuralgia and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, cryptogenic organising pneumonia, pleural effusion, respiratory distress, transaminases increased. CARBAMAZEPINE dosage: unknown. During the same period patient was treated with EPROSARTAN, PRAVASTATIN, ZOLPIDEM TARTRATE, TERAZOSIN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported CARBAMAZEPINE problem on Apr 13, 2007. Female patient, 60 years of age, was diagnosed with convulsion and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, convulsion, impaired driving ability, mental disability. CARBAMAZEPINE dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.
CARBAMAZEPINE problem was reported by a Consumer or non-health professional from GERMANY on Apr 16, 2007. Female patient, 70 years of age, was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, anxiety, delirium, disorientation, gamma-glutamyltransferase increased, hepatic enzyme increased, hypertension, irritability, mood swings. CARBAMAZEPINE dosage: 500 MG QD. During the same period patient was treated with ALPRAZOLAM, MIRTAZAPINE, DIAZEPAM, MELPERON. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported CARBAMAZEPINE problem on May 01, 2007. Male patient, 44 years of age, weighting 255.0 lb, was diagnosed with convulsion and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: confusional state, convulsion, disorientation, incorrect dose administered, mental status changes, staring. CARBAMAZEPINE dosage: 600 MG BID. During the same period patient was treated with VALPROIC ACID, SIMVASTATIN. Patient recovered.
CARBAMAZEPINE problem was reported by a Health Professional from GERMANY on Apr 25, 2007. Male patient, 74 years of age, was diagnosed with bipolar i disorder and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: delusion, insomnia, mania, psychomotor hyperactivity, speech disorder. CARBAMAZEPINE dosage: unknown. During the same period patient was treated with CLOMIPRAMINE, TYLENOL W, LORAZEPAM, SERTRALINE, MIRTAZAPINE, VENLAFAXINE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from GERMANY reported CARBAMAZEPINE problem on Apr 25, 2007. Male patient, 46 years of age, was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: hallucination, auditory, hepatocellular damage, hepatotoxicity, pneumonia. CARBAMAZEPINE dosage: 1000 MG (FREQUENCY NOT STATED). During the same period patient was treated with VENLAFAXINE, LORAZEPAM, PAROXETINE. Patient was hospitalized. Patient recovered.
CARBAMAZEPINE problem was reported by a Consumer or non-health professional from CZECH REPUBLIC on July 20, 2004. Female patient, 72 years of age, was diagnosed with epilepsy, hypothyroidism and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: cerebral ischaemia, condition aggravated, depressed level of consciousness, eyelid oedema, hypothyroidism, sepsis, urinary tract infection. CARBAMAZEPINE dosage: unknown. During the same period patient was treated with PHENYTOIN, LEVOTHYROXINE. Patient was hospitalized. Patient died.
Consumer or non-health professional from JAPAN reported CARBAMAZEPINE problem on Apr 17, 2007. Male patient, 46 years of age, was diagnosed with agitation and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: blood sodium increased, cerebral disorder, diabetes insipidus, stupor. CARBAMAZEPINE dosage: 600MG, QD, ORAL. During the same period patient was treated with LITHIUM CARBONATE, PROMETHAZINE HYDROCHLORIDE, FLUNITRAZEPAM, NIMETAZEPAM, OXATOMIDE. Patient was hospitalized. Patient recovered.
CARBAMAZEPINE problem was reported by a Consumer or non-health professional from FRANCE on Apr 17, 2007. Male patient, 23 years of age, was diagnosed with epilepsy and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, altered state of consciousness, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, cytomegalovirus infection, gamma-glutamyltransferase increased. CARBAMAZEPINE dosage: 200MG, QD, ORAL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from ITALY reported CARBAMAZEPINE problem on May 04, 2007. Male patient, 25 years of age, was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: stevens-johnson syndrome, toxic epidermal necrolysis. CARBAMAZEPINE dosage: 400 MG QD. Patient was hospitalized. Patient recovered.
CARBAMAZEPINE problem was reported by a Consumer or non-health professional from GERMANY on May 04, 2007. Female patient, 70 years of age, was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, crying, delirium, disease recurrence, disorientation, gamma-glutamyltransferase increased, hepatic enzyme increased, hypertension, irritability. CARBAMAZEPINE dosage: 500 MG QD. During the same period patient was treated with ALPRAZOLAM, MIRTAZAPINE, DIAZEPAM, MELPERON. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED KINGDOM reported CARBAMAZEPINE problem on May 09, 2007. Female patient, 63 years of age, was diagnosed with post-traumatic epilepsy and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: abdominal distension, abdominal pain lower, adrenal insufficiency, gastrointestinal disorder, hypotension, multi-organ failure, pituitary infarction, pituitary tumour, thyroid disorder. CARBAMAZEPINE dosage: unknown. During the same period patient was treated with VALPROIC ACID. Patient was hospitalized. Patient died.
CARBAMAZEPINE problem was reported by a Consumer or non-health professional from GERMANY on May 17, 2007. Female patient, 30 years of age, was diagnosed with complex partial seizures and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: mania, rebound effect. CARBAMAZEPINE dosage: unknown. Patient recovered.
Consumer or non-health professional from GERMANY reported CARBAMAZEPINE problem on May 07, 2007. Male patient, 53 years of age, was diagnosed with epilepsy and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: status epilepticus. CARBAMAZEPINE dosage: unknown. Patient was hospitalized. Patient recovered.
CARBAMAZEPINE problem was reported by a Pharmacist from UNITED STATES on May 24, 2007. Male patient, 41 years of age, weighting 203.9 lb, was diagnosed with headache, insomnia, pain and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: depressed level of consciousness, somnolence. CARBAMAZEPINE dosage: unknown. Patient recovered.
Consumer or non-health professional from GERMANY reported CARBAMAZEPINE problem on May 14, 2007. Male patient, 74 years of age, was diagnosed with bipolar i disorder and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: anhedonia, asthenia, delusion, depressed mood, distractibility, elevated mood, feeling abnormal, grandiosity, hepatic enzyme increased. CARBAMAZEPINE dosage: 600 MG QD. During the same period patient was treated with CLOMIPRAMINE, LIOTHYRONINE, LORAZEPAM, THYROXIN T. Patient was hospitalized. Patient recovered.
CARBAMAZEPINE problem was reported by a Health Professional from JAPAN on May 16, 2007. Male patient, 46 years of age, was diagnosed with agitation and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, blood sodium increased, diabetes insipidus, nervous system disorder. CARBAMAZEPINE dosage: 600 MG; QD. During the same period patient was treated with LITHIUM CARBONATE, PROMETHAZINE, HYDROCHLORIDE, FLUNITRAZEPAM, BULOTIZOLAM, NIMETAZEPAM, OXATOMIDE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from ITALY reported CARBAMAZEPINE problem on May 18, 2007. Female patient, 77 years of age, was diagnosed with epilepsy and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: acanthosis, asthenia, cutaneous lupus erythematosus, gamma-glutamyltransferase increased, hyperkeratosis, lupus-like syndrome, myalgia. CARBAMAZEPINE dosage: 400 MG; QD. Patient was hospitalized. Patient recovered.
CARBAMAZEPINE problem was reported by a Consumer or non-health professional from JAPAN on May 18, 2007. Male patient, 32 years of age, was diagnosed with neuralgia and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: nervous system disorder, nuclear magnetic resonance imaging brain abnormal. CARBAMAZEPINE dosage: 600 MG QD PO. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported CARBAMAZEPINE problem on May 16, 2007. Male patient, 30 years of age, was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: ileus, intestinal obstruction, pneumonia aspiration. CARBAMAZEPINE dosage: 200 MG (THREE TIMES A DAY). During the same period patient was treated with THIORIDAZINE, IPECAC, NALOXONE. Patient was hospitalized. Patient recovered.
CARBAMAZEPINE problem was reported by a Consumer or non-health professional from GERMANY on May 17, 2007. Male patient, 74 years of age, was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: mania. CARBAMAZEPINE dosage: 600 MG. During the same period patient was treated with CLOMIPRAMINE HYDROCHLORIDE, LIOTHYRONINE, LORAZEPAM. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported CARBAMAZEPINE problem on May 25, 2007. Female patient, 60 years of age, was diagnosed with convulsion and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: bipolar disorder, condition aggravated, convulsion, mental disorder. CARBAMAZEPINE dosage: 400MG, BID, ORAL. During the same period patient was treated with LITHIUM CARBONATE, RISPERDAL, PROZAC. Patient was hospitalized and became disabled. Patient recovered.
CARBAMAZEPINE problem was reported by a Consumer or non-health professional from ITALY on June 11, 2007. Male patient, 55 years of age, was diagnosed with partial seizures and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: aphasia, cerebral haemorrhage, status epilepticus. CARBAMAZEPINE dosage: 600 MG QD. Patient was hospitalized. Patient recovered.
Health Professional from ITALY reported CARBAMAZEPINE problem on May 22, 2007. Male patient, 55 years of age, was diagnosed with partial seizures and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: aphasia, congenital cerebrovascular anomaly, status epilepticus. CARBAMAZEPINE dosage: 600 MG/DAY. Patient was hospitalized. Patient recovered.
CARBAMAZEPINE problem was reported by a Health Professional from SLOVENIA on May 23, 2007. Male patient, 32 years of age, weighting 125.7 lb, was diagnosed with trigeminal neuralgia and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: fear, sleep disorder, suicidal ideation. CARBAMAZEPINE dosage: 600 MG/DAY. During the same period patient was treated with GABAPENTIN, BACLOFEN. Patient recovered.
Health Professional from SPAIN reported CARBAMAZEPINE problem on May 24, 2007. Male patient, 48 years of age, was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: eosinophilia, hepatic enzyme increased, leukocytosis, lymphadenopathy, pyrexia, rash, skin test positive. CARBAMAZEPINE dosage: unknown. Patient recovered.
CARBAMAZEPINE problem was reported by a Consumer or non-health professional from GERMANY on May 24, 2007. Female patient, 30 years of age, was diagnosed with epilepsy and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: agitation, complex partial seizures, convulsion, decreased appetite, disinhibition, dysphoria, elevated mood, energy increased. CARBAMAZEPINE dosage: 300 MG BID. During the same period patient was treated with VALPROATE, PHENYTOIN. Patient recovered.
Pharmacist from UNITED STATES reported CARBAMAZEPINE problem on June 07, 2007. Female patient, 17 years of age, weighting 180.8 lb, was diagnosed with bipolar disorder and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: face oedema, rash erythematous, rash pruritic. CARBAMAZEPINE dosage: unknown. During the same period patient was treated with QUETIAPINE. Patient was hospitalized. Patient recovered.
CARBAMAZEPINE problem was reported by a Health Professional from UNITED KINGDOM on June 06, 2007. Male patient, 62 years of age, was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: bacteraemia, dry skin, eosinophilia, lymphadenopathy, pyrexia, rash morbilliform, swelling face. CARBAMAZEPINE dosage: unknown. During the same period patient was treated with PHENYTOIN. Patient recovered.
Pharmacist from UNITED STATES reported CARBAMAZEPINE problem on June 08, 2007. Male patient, 79 years of age, weighting 207.7 lb, was diagnosed with neuropathy and was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, biliary tract infection, blood pressure systolic increased, body temperature increased, cholelithiasis, chromaturia, decreased appetite, delirium, electrolyte imbalance. CARBAMAZEPINE dosage: 200MG BID PO. Patient was hospitalized. Patient recovered.
CARBAMAZEPINE problem was reported by a Consumer or non-health professional from JAPAN on May 30, 2007. Female patient, 63 years of age, was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: atrioventricular block complete, atrioventricular block second degree, cerebellar atrophy, cerebral calcification, dyspnoea exertional. CARBAMAZEPINE dosage: 100 MG BID. Patient recovered.
Consumer or non-health professional from GERMANY reported CARBAMAZEPINE problem on May 25, 2007. Female patient, 70 years of age, was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, gamma-glutamyltransferase increased, no therapeutic response. CARBAMAZEPINE dosage: 500MG, QD, ORAL. During the same period patient was treated with ALPRAZOLAM, MELPERONE, DIAZEPAM. Patient was hospitalized. Patient recovered.
CARBAMAZEPINE problem was reported by a Pharmacist from UNITED STATES on June 13, 2007. Female patient, 21 years of age, weighting 158.5 lb, was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: dysphagia, stevens-johnson syndrome. CARBAMAZEPINE dosage: 200MG BID PO. During the same period patient was treated with AMITRIPTYLINE, GABAPENTIN, AMANTADINE, BACLOFEN, INTERFERON BETA, TRINESSA. Patient was hospitalized. Patient recovered.
Showing 1-50 of 354 Next >